Injection of the TLR9 ligand CpG DNA (ODN2395) in mice increased fasting glucose levels and immune cell infiltration in WAT and liver, indicating that even in the absence of obesity TLR9 activation leads to metabolic deregulations (16). Here, TLR9 is linked to obesity disorder.